InsideArbitrage Potential Deal Alert: Novartis (NVS) Weighs Deal For Biotech Avidity (RNA) To Boost Drug Pipeline
The Financial Times reported that Novartis (NVS) has made a takeover approach for rare disease-focused biotech Avidity Biosciences (RNA). Novartis has been evaluating a bid
Read More